Annet S. Kuruvilla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Annet S. Kuruvilla has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Aleksandra Krajewski
Division of Plastic and Reconstructive Surgery, Stony Brook University Hospital, Stony Brook, NY 11794, United States
2 shared publicationsHarmehar K. Kohli
Division of Plastic Surgery, Department of Surgery, Stony Brook University, Renaissance School of Medicine, Stony Brook, New York
2 shared publicationsHenry J. Tannous
Division of Plastic Surgery, Department of Surgery, Stony Brook University, Renaissance School of Medicine, Stony Brook, New York
2 shared publications- Peter William Henderson
Division of Plastic and Reconstructive Surgery, Department of Surgery, Icahn School of Medicine at Mount Sinai, 10 Union Square East, Suite 2 L, New York, NY 10003, United States
2 shared publications Raymond M. Bellis
Division of Plastic Surgery, Department of Surgery, Stony Brook University, Renaissance School of Medicine, Stony Brook, New York
2 shared publicationsSagar R. Mulay
Division of Plastic Surgery, Department of Surgery, Stony Brook University, Renaissance School of Medicine, Stony Brook, New York
2 shared publications
Latest Publications
- 26 September 2022
- Published by Georg Thieme Verlag KG in Journal of Reconstructive Microsurgery
- Vol. 39 (03) , 214-220
Risk Factors Associated with Adverse Outcomes after Ablative Surgery for Lymphedema
Background Postmastectomy breast cancer lymphedema poses an important health threat. Historically, physical therapy was the exclusive treatment option. More recently, lymphedema surgery has revolutionized care. As a first-in-kind, multicenter report, the postmastectomy breast cancer patients' risk factors associated with postlymphedema ablative surgical outcomes were documented. Methods Using the New York Statewide Planning and Research Cooperative System database from 2010 to 2018, multivariable models identified the postmastectomy breast cancer lymphedema surgical patients' characteristics associated with major adverse outcomes and mortality. Results Of 65,543 postmastectomy breast cancer patients, 1,052 lymphedema surgical procedures were performed including 393 (37.4%) direct excisions and 659 (63.6%) liposuctions. Direct excision and liposuction surgical patients had median ages of 58 and 52 years, respectfully (p < 0.001). Although a 30-day operative mortality was rare (0.3%, all direct excisions), major adverse outcomes occurred in 154 patients (28.5% direct excision; 6.4% liposuction; p < 0.0001). Multivariable clinical outcomes model identified that patients with higher Elixhauser's score, renal disease, emergent admissions, and direct excision surgery had higher incidences of adverse outcomes (all p < 0.01). For those patients with 30-day readmissions (n = 60), they were more likely to have undergone direct excision versus liposuction (12.5 vs. 1.7%; p < 0.0001). The important risk factors predictive of future cellulitis/lymphangitis development included diabetes mellitus, Medicaid insurance, renal disease, prior cellulitis/lymphangitis, chronic obstructive pulmonary disease (COPD), and chronic steroid use (all p < 0.01). Conclusion Lymphedema surgery carries a favorable risk profile, but better understanding the “high-risk” patients is critical. As this new era of lymphedema surgery progresses, evaluating the characteristics for adverse postoperative outcomes is an important step in our evolution of knowledge. * Both Ms. Kuruvilla and Dr. Shroyer should be considered co-first authors. ** Both Drs. Tannous and Krajewski should be considered co-last authors. Received: 17 December 2021 Accepted: 29 May 2022 Article published online: 26 September 2022 © 2022. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
- 26 September 2022
- Published by Georg Thieme Verlag KG in Journal of Reconstructive Microsurgery
- Vol. 39 (03) , 214-220
Risk Factors Associated with Adverse Outcomes after Ablative Surgery for Lymphedema
Background Postmastectomy breast cancer lymphedema poses an important health threat. Historically, physical therapy was the exclusive treatment option. More recently, lymphedema surgery has revolutionized care. As a first-in-kind, multicenter report, the postmastectomy breast cancer patients' risk factors associated with postlymphedema ablative surgical outcomes were documented. Methods Using the New York Statewide Planning and Research Cooperative System database from 2010 to 2018, multivariable models identified the postmastectomy breast cancer lymphedema surgical patients' characteristics associated with major adverse outcomes and mortality. Results Of 65,543 postmastectomy breast cancer patients, 1,052 lymphedema surgical procedures were performed including 393 (37.4%) direct excisions and 659 (63.6%) liposuctions. Direct excision and liposuction surgical patients had median ages of 58 and 52 years, respectfully (p < 0.001). Although a 30-day operative mortality was rare (0.3%, all direct excisions), major adverse outcomes occurred in 154 patients (28.5% direct excision; 6.4% liposuction; p < 0.0001). Multivariable clinical outcomes model identified that patients with higher Elixhauser's score, renal disease, emergent admissions, and direct excision surgery had higher incidences of adverse outcomes (all p < 0.01). For those patients with 30-day readmissions (n = 60), they were more likely to have undergone direct excision versus liposuction (12.5 vs. 1.7%; p < 0.0001). The important risk factors predictive of future cellulitis/lymphangitis development included diabetes mellitus, Medicaid insurance, renal disease, prior cellulitis/lymphangitis, chronic obstructive pulmonary disease (COPD), and chronic steroid use (all p < 0.01). Conclusion Lymphedema surgery carries a favorable risk profile, but better understanding the “high-risk” patients is critical. As this new era of lymphedema surgery progresses, evaluating the characteristics for adverse postoperative outcomes is an important step in our evolution of knowledge. * Both Ms. Kuruvilla and Dr. Shroyer should be considered co-first authors. ** Both Drs. Tannous and Krajewski should be considered co-last authors. Received: 17 December 2021 Accepted: 29 May 2022 Article published online: 26 September 2022 © 2022. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
- 7 March 2022
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 75 (7) , 2387-2440
A scoping literature review of post-traumatic lymphedema: Where are we now?
- 7 March 2022
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 75 (7) , 2387-2440
A scoping literature review of post-traumatic lymphedema: Where are we now?
- 1 February 2022
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 75 (2) , 544-549
Nipple-areolar tattoo: Comprehensive review of history, theory, technique, and outcomes
- 1 February 2022
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 75 (2) , 544-549
Nipple-areolar tattoo: Comprehensive review of history, theory, technique, and outcomes
- Open Access
- 17 January 2022
- Published by Taylor & Francis in Case Reports in Plastic Surgery and Hand Surgery
- Vol. 9 (1) , 37-40
Auricular reconstruction after Mohs excision utilizing combination of pre-auricular transposition and chondrocutaneous advancement flaps
Auricular reconstruction can pose a challenge for any well-trained plastic surgeon, especially with the COVID-19 pandemic and pressure to decrease stages and office visits. The case report involves a single-stage reconstruction of the auricular upper-third in an elderly male using a unique combination of pre-auricular fasciocutaneous transposition and chondrocutaneous advancement flaps.
- 17 January 2022
- Published by Taylor & Francis in Case Reports in Plastic Surgery and Hand Surgery
- Vol. 9 (1) , 37-40
Open AccessAuricular reconstruction after Mohs excision utilizing combination of pre-auricular transposition and chondrocutaneous advancement flaps
Auricular reconstruction can pose a challenge for any well-trained plastic surgeon, especially with the COVID-19 pandemic and pressure to decrease stages and office visits. The case report involves a single-stage reconstruction of the auricular upper-third in an elderly male using a unique combination of pre-auricular fasciocutaneous transposition and chondrocutaneous advancement flaps.
- 1 November 2021
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 233 (5) , S201
Risk Factors Associated with Post-Mastectomy Breast Cancer Lymphedema: The New York State Experience
As an edematous condition diminishing quality of life, the risk factors predictive of breast cancer patients’ post-mastectomy lymphedema have not been identified previously. The objective is evaluating trends over time and identifying risk factors predicting breast cancer post-mastectomy lymphedema.
- 1 November 2021
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 233 (5) , S201
Risk Factors Associated with Post-Mastectomy Breast Cancer Lymphedema: The New York State Experience
As an edematous condition diminishing quality of life, the risk factors predictive of breast cancer patients’ post-mastectomy lymphedema have not been identified previously. The objective is evaluating trends over time and identifying risk factors predicting breast cancer post-mastectomy lymphedema.